Last updated: August 30, 2026

Application No. 17/924,064

Methods for Verification of Drug Levels Using Dried Blood Samples

Non-Final OA

Filed

Nov 08, 2022

Priority

May 19, 2020 — EU 20315245.9 +1 more

Examiner

ZEMAN, ROBERT A

Art Unit

1645

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Sanofi S.A.

OA Round

2 (Non-Final)

Interview Optional

— +27.9% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 54% grant rate with +27.9% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 782 resolved cases, 2023–2026

Examiner Intelligence

ZEMAN, ROBERT A View full profile →

Grants 54% of resolved cases

Career Allowance Rate

422 granted / 782 resolved

-6.0% vs TC avg

Strong +28% interview lift

Without

With

+27.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 8m

Avg Prosecution

47 currently pending

Career history

839

Total Applications

across all art units

Statute-Specific Performance

§101

6.1%

-33.9% vs TC avg

§103

23.0%

-17.0% vs TC avg

§102

16.6%

-23.4% vs TC avg

§112

44.7%

+4.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 782 resolved cases

Prosecution Timeline

Show 1 earlier event

Nov 08, 2022

Response after Non-Final Action

Sep 08, 2025

Non-Final Rejection mailed

Nov 18, 2025

Examiner Interview Summary

Nov 18, 2025

Applicant Interview (Telephonic)

Dec 08, 2025

Response Filed

Aug 10, 2026

Request for Continued Examination

Aug 12, 2026

Response after Non-Final Action

Aug 19, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/224,404

Patent 12714742

CLOSTRIDIUM DIFFICILE ANTIGENS

5y 4m to grant Granted Aug 25, 2026

17/203,469

Patent 12691158

ALBUMIN-PROAEROLYSIN PRODRUGS

5y 4m to grant Granted Jul 28, 2026

17/038,813

Patent 12685743

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING PANCREATIC CANCERS

5y 9m to grant Granted Jul 21, 2026

17/686,606

Patent 12667610

VACCINE COMPOSITION COMPRISING RECOMBINANT PROTEIN OF STAPHYLOCOCCUS AUREUS ATTENUATED ENTEROTOXIN AND CYTOTOXIN

4y 3m to grant Granted Jun 30, 2026

18/168,526

Patent 12667595

COMPOSITION FOR PREVENTING, IMPROVING OR TREATING BENIGN PROSTATIC HYPERPLASIA OR ALOPECIA, COMPRISING HEAT-KILLED PROBIOTICS AS ACTIVE INGREDIENT

3y 4m to grant Granted Jun 30, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

54%

Grant Probability

82%

With Interview (+27.9%)

3y 8m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 782 resolved cases by this examiner. Grant probability derived from career allowance rate.